Aptorum Group Limited
- APM
- NASDAQ
- Biotechnology
- Oncology Therapeutics
- Infectious Disease Drugs
- Clinical-Stage Biopharma
$8.26
Today −14.84%Quote Aug 5, 2026, 07:39 PM UTC
−30.50%over the last month
Max drawdown −30.5%From 1-month high −30.5%3 months −35.9%
Our viewPro
The call stays with Pro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Market value
$6.7M
Approximate share count
Next earnings
—
Data unavailable
Latest analyst target
—
Data unavailable
Floor
$8.04
2.7% below price
Where the price sits
No analyst target range for this stock.
The call stays with Pro
7 locked chapters- What to do with this namePro
- Why nowPro
- Why this stockPro
- Section write-upsPro
- Story timelinePro
- News briefPro
- Ask about APMPro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Log in — 14 days freeWhere the money comes from
No revenue split by segment on file.
Industry
Biotechnology
Employees
2
Founded
2010